id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_x3e3txofgfcf7lc3xocschqfta	Federica Dall'Oglio	Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis	2019.0	6	.pdf	application/pdf	3618	908	64	was evaluated at baseline, and at days 15, 30, and 60 by measuring the grade of desquamation, erythema, and pruritus using clinical evaluation, erythema-directed digital photography, Results: After 15 days, a statistically significant decrease from baseline was found in desquamation, erythema, colorimetric scores, and pruritus. Facial seborrheic dermatitis (SD) is a common, chronic, recurrent inflammatory disease clinically characterized by erythema, scaling, and pruritus on sebum-rich areas, The therapeutic efficacy of topical treatments is generally based on clinical evaluation of erythema and/or scaling in the treatment of mild-to-moderate SD by clinical assessment and by erythema-directed photography and colorimetry Table 2 Results from clinical and instrumental assessment of desquamation, erythema, and itch from baseline to study end Figure 2 Standard and erythema-directed digital photography with VISIA-CR of a patient with moderate facial seborrheic dermatitis showing a significant reduction (P<0.001) Figure 2 Standard and erythema-directed digital photography with VISIA-CR of a patient with moderate facial seborrheic dermatitis showing a significant reduction (P<0.001) 	./cache/work_x3e3txofgfcf7lc3xocschqfta.pdf	./txt/work_x3e3txofgfcf7lc3xocschqfta.txt